NEW YORK (GenomeWeb News) – Quest Diagnostics today said that it has sold substantially all of the assets of its OralDNA Labs business to Access Genetics for an undisclosed sum.

The business, which currently provides saliva-based testing from a facility in Tennessee, will be consolidated with Access Genetics' CLIA- and CAP-certified lab in Eden Prairie, Minn. Quest noted that Access Genetics has provided support and expertise for OralDNA-based testing services for dental professionals since 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.